Showing results (51-60 of 63) with videos related to
Sort By:
Pageof 7
Cancer|May 20, 2008
Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosisHiroto Inaba, Ying Fan, Stanley Pounds, et al.Cancer Cell|September 9, 2006
Epm2a suppresses tumor growth in an immunocompromised host by inhibiting Wnt signalingYin Wang, Yan Liu, Cindy Wu, et al.British Journal of Haematology|August 24, 2005
Premedication with acetaminophen or diphenhydramine for transfusion with leucoreduced blood products in childrenRobert P Sanders, Sunil D Maddirala, Terrence L Geiger, et al.Leukemia|February 27, 2018
PI3K orchestration of the in vivo persistence of chimeric antigen receptor-modified T cellsWenting Zheng, Carol E O'Hear, Rajshekhar Alli, et al.Cancer Discovery|February 25, 2025
GPR65 Inactivation in Tumor Cells Drives Antigen-Independent CAR T-cell Resistance via Macrophage RemodelingJayadev Mavuluri, Yogesh Dhungana, Lindsay L Jones, et al.Blood|March 10, 2021
Regnase-1 suppresses TCF-1+ precursor exhausted T-cell formation to limit CAR-T-cell responses against ALLWenting Zheng, Jun Wei, Caitlin C Zebley, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 20, 2014
Bispecificity for myelin and neuronal self-antigens is a common feature of CD4 T cells in C57BL/6 miceLiliana E Lucca, Sabine Desbois, Abdulraouf Ramadan, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 2, 2015
Gut Microbial Dysbiosis Due to Helicobacter Drives an Increase in Marginal Zone B Cells in the Absence of IL-10 Signaling in MacrophagesAvijit Ray, Sreemanti Basu, Raad Z Gharaibeh, et al.Nature|December 13, 2019
Targeting REGNASE-1 programs long-lived effector T cells for cancer therapyJun Wei, Lingyun Long, Wenting Zheng, et al.Genome Medicine|September 1, 2017
The neoepitope landscape in pediatric cancersTi-Cheng Chang, Robert A Carter, Yongjin Li, et al.Pageof 7